Retinoic acid, GABA-ergic, and TGF-β signaling systems are involved in human cleft palate fibroblast phenotype

Molecular Medicine

Volumn 12, Issue 9-10, 2006, Pages 237-245

  Baroni, Tiziano ^a   Bellucci, Catia ^a   Lilli, Cinzia ^a   Pezzetti, Furio ^b   Carinci, Francesco ^c   Becchetti, Ennio ^a   Carinci, Paolo ^b   Stabellini, Giordano ^d   Calvitti, Mario ^a   Lumare, Eleonora ^a   Bodo, Maria ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; FIBRONECTIN; GLUCOSAMINE; GLYCOSAMINOGLYCAN; GROWTH FACTOR; MESSENGER RNA; METHIONINE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SULFUR 35; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA3; TRITIUM;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BINDING ASSAY; CASE REPORT; CELL POPULATION; CLEFT LIP PALATE; CLEFT PALATE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MORPHOGENESIS; NUCLEOTIDE SEQUENCE; PALATOGENESIS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY PALATE; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UPREGULATION;

CELL COUNT; CELL GROWTH PROCESSES; CELL SURVIVAL; CELLS, CULTURED; CHILD, PRESCHOOL; CLEFT PALATE; FEMALE; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION REGULATION; GLUCOSAMINE; GLYCOSAMINOGLYCANS; HUMANS; MALE; PHENOTYPE; RECEPTORS, GABA-A; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA3; TRETINOIN;

EID: 33845513414     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00026.Baroni     Document Type: Article

References (53)

1. Carinci F et al. (2003) Recent developments in orofacial cleft genetics. J. Craniofac. Surg. 14:130-43.
2. Brinkley LL, Morris-Wiman J. (1984) The role of extracellular matrices in palatal shelf closure. Curr. Top. Dev. Biol. 19:17-36.
3. Kochhar DM. (1968) Studies of vitamin A-induced teratogenesis: effects on embryonic mesenchyme and epithelium, and on incorporation of H3-thymidine. Teratology 1:299-310.
4. Young DL, Schneider RA, Hu D, Helms JA. (2000) Genetic and teratogenic approaches to craniofacial development. Crit. Rev. Oral Biol. Med. 11:304-17.
5. Brinkley LL, Morris-Wiman J. (1987) Effects of chlorcyclizine-induced glycosaminoglycan alterations on patterns of hyaluronate distribution during morphogenesis of the mouse secondary palate. Development 100:637-40.
6. Eickelberg O et al. (1999) Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am. J. Physiol. Lung Cell Mol. Physiol. 276:L814-24.
7. Taipale J, Keski-Oja J. (1997) Growth factors in the extracellular matrix. FASEB J. 11:51-9.
8. Morris-Wiman J, Brinkley L. (1992) An extracellular matrix infrastructure provides support for murine secondary palatal shelf remodelling. Anat. Rec. 234:575-86.
9. Pratt RM, Goggins JF, Wilk AL, King CT. (1973) Acid mucopolysaccharide synthesis in the secondary palate of the developing rat at the time of rotation and fusion. Dev. Biol. 32:230-7.
10. Singh GD, Moxham BJ, Langley MS, Waddington RJ, Embery G. (1994) Changes in the composition of glycosaminoglycans during normal palatogenesis in the rat. Arch. Oral Biol. 39:401-7.
11. Young AV, Hehn BM, Cheng KM, Shah RM. (1994) A comparative study on the effects of 5-fluorouracil on glycosaminoglycan synthesis during palate development in quail and hamster. Histol. Histopathol. 9:515-23.
12. Lidral AC et al. (1998) Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am. J. Hum. Genet. 63:557-68.
13. Proetzel G et al. (1995) Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11:409-14.
14. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. (1995) Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:415-21.
15. Brunet CL, Sharpe PM, Ferguson MW. (1995) Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int. J. Dev. Biol. 39:345-55.
16. Massaguè J, Hata A, Liu F. (1997) TGFbeta signaling through the Smad pathway. Trends Cell Biol. 7:187-92.
17. Roberts AB, Sporn MB. (1992) Mechanistic interrelationships between two superfamilies: the steroid/retinoid receptors and transforming growth factor-beta. Cancer Surv. 14:205-20.
18. Nugent P, Greene RM. (1994) Interactions between the transforming growth factor beta (TGF-β) and retinoic acid signal transduction pathways in murine embryonic palatal cells. Differentiation 58:149-55.
19. Pendaries V, Verrecchia F, Michel S, Mauviel A. (2003) Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner. Oncogens 22:8212-20.
20. Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, Wotton D. (2006) TGIF inhibits retinoid signaling. Mol. Cell. Biol. 26:990-1001.
21. Kawakami Y, Raya A, Raya RM, Rodriguez-Esteban C, Belmonte JC. (2005) Retinoic acid signaling links left-right asymmetric patterning and bilaterally symmetric somitogenesis in the zebrafish embryo. Nature 435:165-71.
22. Morriss-Kay G. (1993) Retinoic acid and craniofacial development: molecules and morphogenesis. Bioessays 15:9-15.
23. Helms JA, Kim CH, Hu D, Minkoff R, Thaller C, Eichele G. (1997) Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid. Dev. Biol. 187:25-35.
24. Cuervo R, Valencia C, Chandraratna RA, Covarrubias L. (2002) Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid. Dev. Biol. 245:145-56.
25. Song HM, Nacamuli RP, Xia W, Bari AS, Shi YY, Fang TD, Longaker MT. (2005) High-dose retinoic acid modulates rat calvarial osteoblast biology. J. Cell. Physiol. 202:255-62.
26. Cohen MM Jr. (1991) Etiopathogenesis of craniosynostosis. Neurosurg. Clin. N. Am. 2:507-13.
27. Degitz SJ, Francis BM, Foley GL. (1998) Mesenchymal changes associated with retinoic acid induced cleft palate in CD-1 mice. J. Craniofac. Genet. Dev. Biol. 18:88-99.
28. Damm K, Heyman RA, Umesono K, Evans RM. (1993) Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. U. S. A. 90:2989-93.
29. Scapoli L, Martinelli M, Pezzetti F, Carinci F, Bodo M, Tognon M, Carinci P. (2002) Linkage disequilibrium between GABRB3 gene and non-syndromic familial cleft lip with or without cleft palate. Hum. Genet. 110:15-20.
30. Chenevix-Trench G, Jones K, Green AC, Duffy DL, Martin NG. (1992) Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci. Am. J. Hum. Genet. 51:1377-85.
31. Shaw D, Ray A, Marazita M, Field L. (1993) Further evidence of a relationship between the retinoic acid receptor alpha locus and nonsyndromic cleft lip with or without cleft palate (CL +/- P). Am. J. Hum. Genet. 53:1156-7.
32. Stein JD, Hecht JT, Blanton SH. (1995) Exclusion of retinoic acid receptor and a cartilage matrix protein in non-syndromic CL(P) families. J. Med. Genet. 32:78.
33. Moreno LM et al. (2004) Genetic analysis of candidate loci in non-syndromic cleft lip families from Antioquia-Colombia and Ohio. Am. J. Med. Genet. A 125:135-44.
34. Ding R, Tsunekawa N, Obata K. (2004) Cleft palate by picrotoxin or 3-MP and palatal shelf elevation in GABA-deficient mice. Neurotoxicol. Teratol. 26:587-92.
35. Homanics GE et al. (1997) Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. U. S. A. 94:4143-8.
36. Conrad GW, Hamilton C, Haynes E. (1977) Differences in glycosaminoglycans synthesized by fibroblast-like cells from chick cornea, heart and skin. J. Biol. Chem. 252:6861-70.
37. Bodo M et al. (1997) Apert's syndrome: differential in vitro production of matrix macromolecules and its regulation by interleukins. Eur. J. Clin. Invest. 27:36-42.
38. Massaguè J. (1987) Identification of receptors for type-beta transforming growth factor. Methods Enzymol. 146:174-95.
39. Bosi G et al. (1998) Diphenylhydantoin affects glycosaminoglycans and collagen production by human fibroblasts from cleft palate patients. J. Dent. Res. 77:1613-21.
40. Bodo M et al. (1999) TGFbeta isoforms and decorin gene expression are modified in fibroblasts obtained from non-syndromic cleft lip and palate subjects. J. Dent. Res. 78:1783-90.
41. Baroni T et al. (2003) Cross-talk between interleukin-6 and transforming growth factor-beta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate. J. Periodontol. 74:1447-53.
42. Irving DW, Willhite CC, Burk DT. (1986) Morphogenesis of isotretinoin-induced microcephaly and micrognathia studied by scanning electron microscopy. Teratology 34:141-53.
43. Edward M. (1995) Effects of retinoids on glycosaminoglycan synthesis by human skin fibroblasts grown as monolayers and within contracted collagen lattices. Br J Dermatol. 133:223-30.
44. D'Angelo M, Greene RM. (1991) Transforming growth factor-beta modulation of glycosaminoglycan production by mesenchymal cells of the developing murine secondary palate. Dev. Biol. 145:374-8.
45. Loeys BL et al. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37:275-81.
46. De Luca LM. (1991) Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5:2924-33.
47. Nugent P, Ma L, Greene RM. (1998) Differential expression and biological activity of retinoic acid-induced TGFbeta isoforms in embryonic palate mesenchymal cells. J. Cell. Physiol. 177:36-46.
48. Degitz SJ, Morris D, Foley GL, Francis BM. (1998) Role of TGF-beta in RA-induced cleft palate in CD-1 mice. Teratology 58:197-204.
49. Makhijani NS, Bischoff DS, Yamaguchi DT. (2005) Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms. J. Cell. Physiol. 202:304-13.
50. Harnish DC, Jiang H, Soprano KJ, Kochhar DM, Soprano DR. (1992) Retinoic acid receptor beta 2 mRNA is elevated by retinoic acid in vivo in susceptible regions of mid-gestation mouse embryos. Dev. Dyn. 194:239-46.
51. Wee EL, Zimmerman EF. (1983) Involvement of GABA in palate morphogenesis and its relation to diazepam teratogenesis in two mouse strains. Teratology 28:15-22.
52. Condie BG, Bain G, Gottlieb DI., Capecchi MR. (1997) Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc. Natl. Acad. Sci. U. S. A. 94:11451-5
53. Song XQ, Meng F, Ramsey DJ, Ripps H, Qian H. (2005) The GABA rho1 subunit interacts with a cellular retinoic acid binding protein in mammalian retina. Neuroscience 136:467-75.